Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Integra Flowable Matrix
- Development stage
- Unknown
- Lead developer
- Integra LifeSciences
- Modality
- Recombinant Proteins and Enzymes
- Administration
- Topical, Subcutaneous
01
Overview
Integra Flowable Matrix is an advanced 3-D porous wound matrix composed of granulated cross-linked bovine tendon collagen and glycosaminoglycan (specifically chondroitin-6-sulfate). It is designed for the management of deep, tunneled, or irregularly shaped wounds, such as diabetic foot ulcers. The matrix acts as a scaffold that supports cellular invasion and capillary growth, facilitating dermal regeneration and tissue healing. It is typically hydrated with saline before application to the wound bed, allowing it to conform to complex wound geometries.
- Brand names
- INTEGRA Flowable Wound Matrix
- Other names
- Integra Flowable
Beyond the preview
Go deeper on Integra Flowable Matrix.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Integra Flowable Matrix.